Does Zepbound Cause Low Blood Pressure?
Zepbound (tirzepatide) lists low blood pressure (hypotension) as a possible side effect in its prescribing information, though it's not among the most common ones like nausea or diarrhea. Clinical trials reported hypotension in less than 1% of patients, often linked to dehydration from gastrointestinal effects or use with blood pressure-lowering drugs.[1][2]
How Common Is Hypotension with Zepbound?
In the SURMOUNT trials for weight loss, hypotension occurred in 0.5-1.2% of Zepbound users, compared to 0.3% on placebo. Rates were higher in those with pre-existing low blood pressure or on antihypertensives. Post-marketing reports note rare cases of symptomatic hypotension, especially during dose escalation.[1][3]
Why Might Zepbound Lower Blood Pressure?
Tirzepatide activates GLP-1 and GIP receptors, slowing gastric emptying and reducing appetite, which can lead to fluid loss and lower blood volume. This effect mimics some GLP-1 drugs like semaglutide (Wegovy/Ozempic), where blood pressure drops average 2-5 mmHg systolic in trials. Heart rate may increase slightly as a compensatory response.[2][4]
Who Is at Higher Risk?
Patients over 65, those with heart conditions, or on diuretics/ACE inhibitors face elevated risk. Dehydration from vomiting/diarrhea amplifies it—drink fluids and monitor BP during the first weeks. FDA warns of orthostatic hypotension (dizziness upon standing).[1][5]
What Should You Do If BP Drops?
Stop Zepbound and seek medical help if systolic BP falls below 90 mmHg or symptoms like dizziness, fainting, or fatigue appear. Doctors may adjust doses or add electrolytes. Regular home monitoring is advised for at-risk users.[1][2]
How Does Zepbound Compare to Similar Drugs?
| Drug | Hypotension Rate in Trials | Avg. Systolic BP Change |
|------|-----------------------------|-------------------------|
| Zepbound (tirzepatide) | <1% | -4 to -6 mmHg [2] |
| Wegovy (semaglutide) | 1-2% | -3 to -5 mmHg [4] |
| Mounjaro (tirzepatide, diabetes) | 0.4% | -5 mmHg [3] |
| Saxenda (liraglutide) | <1% | -2 mmHg [6] |
Zepbound shows similar or slightly stronger BP-lowering than single GLP-1 agonists, tied to greater weight loss (15-20% body weight).[2][4]
When to Talk to Your Doctor
Discuss if you have low baseline BP (<100/60 mmHg), kidney issues, or take BP meds. No Zepbound patent data directly ties to this side effect; generics/biosimilars aren't available yet (patent expiry ~2035-2036).7
[1]: Zepbound Prescribing Information, Eli Lilly, FDA.gov
[2]: SURMOUNT-1 Trial, NEJM 2022
[3]: Mounjaro Label, FDA
[4]: Wegovy Trials, Novo Nordisk
[5]: FDA Adverse Event Reporting, Zepbound
[6]: Saxenda Label, FDA